Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-14.42x22.25x4.26x797.32x-12.17x-12.06x-.--% 5.49B
17.93x3.94x2.13x5.93x12.15x13.85x1.71% 56.7B
30.64x5.82x0.79x7.55x23.21x23.69x0.05% 51.97B
-18.24x1.12x2.82x4.35x-7.62x-6.42x-.--% 23.33B
-37.99x49.76x0.64x12.2x-35.93x-39.68x-.--% 21.34B
24.11x2.74x-1.14x4.7x15.27x17.22x-.--% 17.44B
44.73x11.47x0.4x18.1x46.61x42.76x0.08% 14.77B
17.37x4.93x1.24x5.01x11.7x12.63x-.--% 13.84B
-26.49x28.59x-0x25.4x-31.82x-25.4x-.--% 12.12B
-76.33x24.81x1.5x6.97x-57.58x-56.36x-.--% 11.14B
-11.96x-83.06x5.3x86.77x-13.52x-13.14x-.--% 10.38B
-10.77x38.41x0.7x2402.7x-12.73x-11.07x-.--% 10.41B
-17.75x8.82x3.8x113.83x-15.92x-14.47x - 8.83B
-30.89x8.49x-0.56x - -28.47x-27.54x-.--% 8.35B
-6.29x - -0.12x - -6.44x-5.92x-.--% 7.73B
-8.54x - -0.07x - - - - 7.49B
16.54x4.89x0.52x - - - 0.43% 7.05B
51.66x1.85x0.27x3.98x17.93x33.27x0.16% 7.26B
-17.03x19.93x-3.02x665.1x-18.78x-15.87x-.--% 6.64B
35.18x1.49x-0.79x5.1x13.81x36.49x - 6.41B
Average -1.93x 8.68x 0.93x 260.31x -5.57x -2.67x 0.14% 15.43B
Weighted average by Cap. 4.16x 8.59x 1.15x 135.45x 1.25x 2.85x 0.37%
Bio Therapeutic Drugs